What is the current stock price of InfuSystem Holdings, Inc. (INFU)?

As of the latest market data, InfuSystem Holdings, Inc. (INFU) is trading at $9.38. The stock has seen a loss of -2.49% today.

Does InfuSystem Holdings, Inc. (INFU) pay a dividend?

Based on current data, InfuSystem Holdings, Inc. does not have a confirmed active dividend policy.

What is the market cap of InfuSystem Holdings, Inc.?

The current market capitalization of InfuSystem Holdings, Inc. (INFU) is approximately unavailable.

INFU

InfuSystem Holdings, Inc.·Healthcare

9.38

2.495%(−0.24)

Market Closed

9.98

6.397%(+0.60)

After Hours

Last Updated: — ET

52W L: $4.6652W H: $11.04

INFU NEWS

businesswire.com

Mar 16

InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026.

defenseworld.net

Mar 9

Reviewing InfuSystem (NYSE:INFU) and Nemaura Medical (OTCMKTS:NMRD)

InfuSystem (NYSE: INFU - Get Free Report) and Nemaura Medical (OTCMKTS:NMRD - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability. Profitability This table compares InfuSystem and Nemaura Medical's net

seekingalpha.com

Feb 24

InfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call Transcript

zacks.com

Feb 24

InfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat Estimates

InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.04 per share a year ago.

businesswire.com

Feb 24

InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025.

businesswire.com

Feb 17

InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026.

Company Profile

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

502

IPO Date

2007-12-27

Beta

1.55

Websitewww.infusystem.com↗